Core Viewpoint - The company successfully completed a new H-share placement, issuing 35 million shares and raising approximately HKD 562.1 million, reflecting strong market confidence in its "data-AI-scenario" ecosystem and strategic value [1][2] Group 1: Financial Performance and Market Response - The placement attracted significant interest from long-term and medical specialty funds, resulting in multiple times oversubscription, indicating deep market recognition of the company's core value and growth potential [1][2] - The funds raised will be directed towards three key areas, providing strong momentum for the company's long-term development [2] Group 2: Business Expansion and Strategic Partnerships - The company has established a service network covering 115 imaging centers, with nearly 10 million new medical imaging data cases annually, making it one of the largest and fastest-growing medical imaging databases in China [1] - The company is accelerating its overseas strategy, having formed an alliance with Hong Kong's Yisi Health to establish imaging centers, with plans to expand into new markets such as Singapore, Malaysia, and the Middle East by H2 2025 [2] Group 3: Technological Advancements - The company has launched the world's first full-modal, full-process medical imaging foundation model, "MIIA Miya," with the first AI product set to be released in Q3 2025, enhancing its competitive edge in the medical AI sector [1] - The business model combines data-driven algorithms with practical applications, creating a commercial loop that is highly valued by international capital [1]